Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Healthcare Minors topic
No spam. Unsubscribe anytime.
Georgia Senate approves ban on puberty blockers for minors after heated debate
Summary
The Georgia Senate passed SB 30, prohibiting hospitals and physicians from prescribing puberty blockers and certain hormone therapies to minors for gender dysphoria. An amendment to grandfather some current patients failed 20–34; the final passage vote was 34–19.
The Georgia Senate on March 3 approved SB 30, a bill that would prohibit hospitals and physicians from prescribing puberty blockers and certain hormone therapies to minors for gender dysphoria. The measure passed after several hours of floor debate and the defeat of a last-minute amendment that would have allowed limited continued treatment for children already receiving puberty blockers.
Supporters, led on the floor by Senator Watson (Senator Watson, 1st District), said the bill narrowly targets medical interventions for minors. “This bill outlaws puberty blockers for minors, specifically in gender dysphoria,” Watson said, adding the measure does not prevent access to counseling. Watson and other proponents pointed to reported medical risks and urged the legislature to protect children from treatments they described as experimental for minors.
Opponents framed the vote as an intrusion into medical decisions and parental authority. Senator Perrin (Senator Perrin, 40th District), who offered Amendment 1 to allow minors already on puberty blockers to continue treatment, said abrupt withdrawal could harm young patients and increase risks, including mental-health crises. “Forcing someone abruptly to stop taking these medications while incarcerated or otherwise can and will cause severe physical and psychological distress,” Perrin said on the floor while urging adoption of the amendment.
The Senate voted down Amendment 1, 20–34. The roll-call on final passage recorded 34 yeas and 19 nays. Supporters argued the bill is limited to medical interventions for minors; critics said leading medical groups back some uses of puberty blockers and warned of legal and health consequences if care is restricted.
The bill includes criminal penalties for knowingly furnishing specified material to minors in other sections; the sponsor and committee said the measure was drafted to be specific and to include an affirmative defense for librarians and other professionals in a different bill (SB 74) adopted separately. The Senate’s floor debate included extended remarks about clinical evidence, referenced professional medical organizations, and numerous personal appeals from members.
SB 30 moves to the next step in the legislative process pending final enrollment and further review. The bill’s authors and opponents both indicated litigation is likely if the law is enacted, and several senators urged careful review of medical evidence and federal precedent.
Ending: With the amendment defeated and the bill approved, sponsors said they expect litigation and guidance to follow; opponents said they will continue to press medical and constitutional arguments in court and in the public debate.
